Thank you, Joelle, and good morning, everyone. I'll start with second quarter results on Slide 10. Our second quarter revenues were up an impressive 15% year-over-year, coming in at $449 million, marking our fifth consecutive quarter of positive year-over-year revenue growth. As Joelle discussed, the underlying business continued to perform very well in Q2. Excluding the benefits to base from Joelle's mentioned customer initiatives, we estimate Q2 total revenue growth was still a very robust 11% to 12%, above both our previously communicated expectations and long-term growth algorithm target range. Adjusted EBITDA for the second quarter was $128.5 million, up 13% year-over-year. Our adjusted EBITDA margin of 28.6% came in above our stated expectations and reflects sequential quarterly improvement of 130 basis points, driven by strong operating leverage. Notably, we efficiently fulfilled the incremental Q2 volume within our existing cost structure without having to make structural changes to our operating model. Margins benefited from our strong execution on synergies and cost discipline while flexing to adapt to the product mix changes as a result of the large deals we have previously -- we have discussed previously, particularly as the positive base trends have provided more broad-based revenue distribution compared to what we saw in late 2025. Our adjusted diluted EPS was $0.35 per share, a 30% increase year-over-year. Our per share earnings growth was supported by our overall outperformance in the quarter, share buybacks and synergy realization. Earnings growth also benefited from our disciplined expense and capital management, combined with lower interest expense as a result of our debt repricing and voluntary debt prepayment. We continue to action cost synergies from our Sterling acquisition, reflecting our disciplined execution and strong integration progress. We remain on track to achieve our synergy goal within 2 years post closing. And as of quarter end, we had actioned $63 million in run rate acquisition synergies, moving closer to our total synergy goal of $65 million to $80 million. Overall, our outstanding Q2 results were enabled by our go-to-market momentum and execution, combined with our ability to flex to meet our customers' demand. Now turning to cash flow, net leverage and capital allocation on Slide 11. During the quarter, we generated operating cash flows of $73.6 million, a substantial increase of $36.3 million or 97% on a year-over-year basis. This impressive performance was driven by our revenue outperformance in the quarter, the larger scale of our business, our overall focus on cash flow and the curtailment of acquisition-related outflows. Our cash balance as of June 30, 2026, was $238 million. We are constantly evaluating our capital allocation options for driving shareholder value creation, remaining focused on opportunistic capital deployment across both deleveraging and share repurchasing. Achieving our target net leverage level of less than 3x remains a top priority and the pace of our debt paydown reflects that commitment. In line with this, just this week, we prepaid $45 million of debt, well exceeding the voluntary prepayments we've made each quarter for the last year. This is in addition to the previously announced $25 million prepayment we made on May 6 and brings our total debt repayment to $165.5 million since closing on the Sterling acquisition. As a result, our synergized adjusted EBITDA net leverage ratio at quarter end was 3.7x and represents a 0.7x decrease from when we closed the Sterling acquisition. Additionally, during the quarter, we repurchased $18.7 million of our shares through the $100 million share repurchase authorization that we announced in February. Our repurchases through the end of July totaled approximately $38 million with an average purchase price of $11.78 per share. This represents 3.2 million shares in total or approximately 1.9% of total shares outstanding. $61.8 million remains on our authorization. Going forward, we will continue to analyze our capital allocation approach to ensure we are opportunistically actioning a plan that maximizes ROI and shareholder value. Moving to Slide 12 and our 2026 guidance. Today, we are raising our previously announced full year guidance, supported by our exceptional performance in the first half of the year and our outlook for stability in the hiring market for the remainder of the year. We now expect 2026 total revenues in the range of $1.67 billion to $1.71 billion, adjusted EBITDA of $472 million to $486 million, adjusted net income of $214 million to $225 million and adjusted diluted EPS of $1.23 to $1.29 per share. At the midpoint, this represents approximately 7% year-over-year revenue growth, 9% year-over-year adjusted EBITDA growth and 21% year-over-year adjusted diluted EPS growth. Our updated and tightened guidance range reflects a balanced posture on our short-term outlook that incorporates the healthy state of our underlying demand trends as well as the ongoing geopolitical and macro uncertainty. As a result, the continuation of current trends would support performance above the midpoint of our range. However, consistent with our historical approach towards guidance, we believe it is prudent to account for a broader range of outcomes given the factors outside of our control. As we think about the second half of the year, please remember that our 2026 growth rates are being measured against an exceptionally strong second half of 2025, during which we grew a notable 12% year-over-year in Q4 2025. Notably, in Q3 of this year, we begin to lap the 12-month anniversary of the large 2025 go-lives we have discussed previously. And by Q4, those wins will be fully annualized. As we progress through the second half of the year, we expect that this will result in moderating growth rates compared to the exceptional start to this year. Zooming out, while growth rates may fluctuate from quarter-to-quarter, we expect to deliver full year results above our original expectations and in line with our long-term growth algorithm. Looking specifically at Q3, we saw revenue momentum continuing from Q2 into July, and we expect base to be slightly positive for the full quarter. Taken together with the new logo and upsell cross-sell trends we've discussed, we expect total revenue growth rates for Q3 in the mid- to high single digits, consistent with the expectations we shared last quarter. Looking ahead at Q4, we expect base to be neutral with our overall base momentum continuing into Q4, but partially offset by prior year's Q4 new logo and upsell cross-sell revenue being more evenly distributed across 2026, the dynamic we've been discussing with you for several quarters. For Q4, we also have a more modest level of expected new logo and upsell cross-sell contribution models as we comp against the strong Q4 2025 17% growth and navigate some instances of recent win implementations now extending into early 2027. As a result, we expect Q4 total revenue growth rate in the low to mid-single digits. Turning to adjusted EBITDA. Overall, we expect adjusted EBITDA margins to remain largely consistent with Q2 for the remainder of the year. And similarly, for adjusted diluted EPS, we expect meaningful year-over-year expansion, increasing versus prior year to the low to mid-$0.30 range in both Q3 and Q4. Having walked through our updated 2026 guidance, I want to close on Slide 13. This slide puts our 2026 guidance in the context of our longer-term growth trend in adjusted diluted EPS. The growth implied by our updated 2026 guidance midpoint is consistent with our track record of adjusted diluted EPS growth of 20% or more since 2024. This is also consistent with the longer-term adjusted diluted EPS growth rate implied by the midpoint of our 2028 target. With that, let me turn it back to Scott for closing remarks before we open the line for your questions.